IPCA Laboratories Share Price Surges 7% to Hit 52-Week High: Is This the Next Big Pharma Stock?
IPCA Laboratories' share price surged 7% to hit a 52-week high on Oct 23 after the company received a voluntary action indicated (VAI) classification for its Ratlam plant from the US FDA. What's a VAI classification and why is it good news for IPCA Laboratories?
Written By: Zee Business Video Team